White label ELPA - ClinicalTrials.eu

Study on the Safety of Eganelisib Alone and with Cytarabine for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Higher-Risk Myelodysplastic Syndromes

Recruiting

1 1 1 1
Investigated Diseases:
- Acute myeloid leukaemia refractory
- Acute myeloid leukaemia recurrent
Investigated Drugs:
- EGANELISIB
- Cytarabine
Long-term Follow-up Study for Patients with Relapsed/Refractory T-cell Acute Lymphoblastic Leukemia/Lymphoma Treated with OC-1 Cells

Recruiting

3 1 1
Investigated Drugs:
- Autologous T-Cells Ex Vivo Modified With A Lentiviral Vector Encoding A Chimeric Antigen Receptor Specific For Cd1A
Study on Vedolizumab and Ustekinumab for Patients with Crohn’s Disease and Ulcerative Colitis

Recruiting

3 1 1 1
Investigated Diseases:
- Colitis ulcerative
- Crohn’s disease
Investigated Drugs:
- Ustekinumab
- Vedolizumab
Study on MaaT033 and Cemiplimab for Patients with Advanced Non-Small Cell Lung Cancer Resistant to PD-1/PD-L1 Blockade Due to Antibiotic Use

Recruiting

2 1 1 1
Investigated Diseases:
- Non-small cell lung cancer
Investigated Drugs:
Study on Dapagliflozin, Finerenone, and Semaglutide for Treating Chronic Kidney Disease in Patients

Recruiting

3 1 1 1
Investigated Diseases:
- Chronic kidney disease
Investigated Drugs:
- Finerenone
- Semaglutide
Study on Preoperative Antibiotics for Patients with Acute Cholecystitis: Comparing Ertapenem, Ciprofloxacin, and Cefuroxime

Recruiting

3 1 1 1
Investigated Diseases:
- Cholecystitis acute
Investigated Drugs:
Study of inavolisib, palbociclib and letrozole combination for patients with advanced hormone receptor-positive, HER2-negative breast cancer with PIK3CA mutation

Recruiting

3 1 1
Investigated Diseases:
- Breast cancer
Investigated Drugs:
Study on Mannitol and Normal Saline for Patients with End-Stage Renal Disease Undergoing Kidney Transplantation

Recruiting

3 1 1 1
Investigated Diseases:
- End stage renal disease
- Renal transplant
Investigated Drugs:
- Mannitol
Study of Ifinatamab Deruxtecan and Pembrolizumab, With or Without Chemotherapy, for Patients With Untreated Advanced Esophageal Cancer

Recruiting

1 1 1 1
Investigated Drugs:
Study on the Safety and Effects of BMS-986507 with Pembrolizumab and Osimertinib Mesylate in Adults with Advanced Solid Tumors

Recruiting

1 1 1 1
Investigated Diseases:
- Neoplasm malignant
Investigated Drugs:
- OSIMERTINIB MESYLATE
- Pembrolizumab

Full Name *

e-Mail *

Country Prefix *

Phone Number *

Nationality *

Gender *

Check all consents

Check all consents

I accept the Terms and Conditions and Privacy Policy *

*I accept the Terms and Conditions and Privacy Policy

I consent to receiving commercial information from the Service Operator *

*I consent to receiving commercial information from the Service Operator

I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes *

*I consent to the use of telecommunications terminal equipment and automated calling systems by the Service Operator for marketing communication purposes

We use cookies